Evidence map›Paper›PMID 33771277›Full record

ArticleJournal of substance abuse treatment2021

Integrated substance use and prenatal care delivery in the era of COVID-19.

Elizabeth W Patton, Kelley Saia, Michael D Stein

Abstract read
In one paragraph

Article in Journal of substance abuse treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Telemedicine Implementation for Safety Net Populations: A Systematic Review.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Conjoint Analysis of Telemedicine Preferences for Hypertension Management Among Adult Patients.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Changes in methadone take-home dosing before and after COVID-19.Journal of substance abuse treatment · 2022
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elizabeth W PattonBoston University School of Medicine, Department of Obstetrics and Gynecology, 85 East Concord St, 6th Floor, Boston, MA 02118, United States of America; Boston Medical Center, 850 Harrison Ave, Boston, MA 02118, United States of America. Electronic address: Elizabeth.Patton@bmc.org.
Kelley SaiaBoston University School of Medicine, Department of Obstetrics and Gynecology, 85 East Concord St, 6th Floor, Boston, MA 02118, United States of America; Boston Medical Center, 850 Harrison Ave, Boston, MA 02118, United States of America. Electronic address: Kelley.Saia@bmc.org.
Michael D SteinBoston University School of Public Health, Department of Health Law, Policy and Management, 715 Albany St, Talbot Building, Boston, MA 02118, United States of America. Electronic address: mdstein@bu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has directly impacted integrated substance use and prenatal care delivery in the United States and has driven a rapid transformation from in-person prenatal care to a hybrid telemedicine care model. Additionally, changes in regulations for take home dosing for methadone treatment for opioid use disorder due to COVID-19 have impacted pregnant and postpartum women. We review the literature on prenatal care models and discuss our experience with integrated substance use and prenatal care delivery during COVID-19 at New England's largest safety net hospital and national leader in substance use care. In our patient-centered medical home for pregnant and postpartum patients with substance use disorder, patients' early responses to these changes have been overwhelmingly positive. Should clinicians continue to use these models, thoughtful planning and further research will be necessary to ensure equitable access to the benefits of telemedicine and take home dosing for all pregnant and postpartum patients with substance use disorder.

Indexed as

COVID-19Delivery of Health Care, IntegratedOpioid-Related DisordersPrenatal CareTelemedicineFemaleHumansNew EnglandPostpartum PeriodPregnancySafety-net ProvidersUnited StatesCOVID-19Prenatal careSubstance use treatmentTelemedicine

Identifiers

PMID33771277
PMCPMC7979279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.